Podcast Index

Podcasts

Browse podcasts by category, open recent episodes, and download audio to listen offline.

Decera Clinical Education Oncology Podcast Decera Clinical Education Oncology Podcast Decera Clinical Education Ö1 Wissen aktuell Ö1 Wissen aktuell ORF Ö1 SintonIA. La IA en las ondas. SintonIA. La IA en las ondas. Radiolab UGR Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc! Thrilling Threads - Conspiracy Theories, Strange Phenomena, True Crime, Unsolved Mysteries, etc! Byte & Pieces Relatos De Horror (Historias De Terror) Relatos De Horror (Historias De Terror) Relatos De Horror منوعات إسلامية منوعات إسلامية تعليم عقيدة رسول الله Live Like a Girl with Dr. Mindy Pelz Live Like a Girl with Dr. Mindy Pelz Dr. Mindy Pelz Genome Insider Genome Insider JGI The 365 Days of Astronomy The 365 Days of Astronomy 365DaysOfAstronomy.org On The Wing Podcast On The Wing Podcast On The Wing Podcast by Pheasants Forever and Quail Forever Talking Pools Podcast Talking Pools Podcast Rudy Stankowitz Redox Grows Redox Grows Redox Bio-Nutrients Los Angeles Weather Daily Los Angeles Weather Daily Fast Foundations Phoenix Weather Daily Phoenix Weather Daily Fast Foundations San Diego Weather Daily San Diego Weather Daily Fast Foundations Ag Geek Speak Ag Geek Speak A Podcast for Precision Agriculture Geeks San Francisco Weather Daily San Francisco Weather Daily Fast Foundations Wildlife Investments Wildlife Investments Moriah Boggess The Swine Health Blackbelt Podcast The Swine Health Blackbelt Podcast Wisenetix Astronomy Daily: Space News Updates Astronomy Daily: Space News Updates bitesz.com Kohn's Zone Kohn's Zone Alfie Kohn Risky or Not? Risky or Not? Don Schaffner and Ben Chapman xHUB.AI xHUB.AI Plácido Doménech Espí The Real Truth About Health Free 17 Day Live Online Conference Podcast The Real Truth About Health Free 17 Day Live Online Conference Podcast Lloyd Burrell, Keith Block M.D., Jeffrey Smith, Michael Klaper M.D., Ralph Moss, Brenda Davis R.D., Mark Sloan, Gerald Posner, Ian Harris M.D., Neil Barnard M.D., Will Tuttle Ph.D., John McDougall M.D., Pam Popper Ph.D., Gabriel Cousens M.D., Brian Clement Ph.D., Anna Maria Clement Ph.D., Marianne Williamson, Vandana Shiva Ph.D., Aly Cohen M.D., Milton Mills M.D., Theodora Scarato, William Li M.D., David Katz M.D., Stephanie Seneff Ph.D., Julieanna Hever M.S., Dale Bredesen M.D., Hope Bohanec, Kim Williams M.D., Joel Kahn M.D., Michelle Perro M.D., David Wolfe, Melanie Joy Ph.D., Sunil Pai M.D., Baxter Montgomery M.D., Michael Greger M.D., Caldwell Esselstyn M.D., Joel Fuhrman M.D., Colin Campbell Ph.D. The Nova Society The Nova Society Dr. Mark George Bound, Dr. Scott Gerschwer, & Dr. Brooklynn Ann Welden Peaks to Power Peaks to Power National Laboratory of the Rockies Bad at Goodbyes Bad at Goodbyes Joshua Dumas Passive House Podcast Passive House Podcast Matthew Cutler-Welsh, Zack Semke, Mary James, and Ilka Cassidy 🎙️ Science News Daily | Peer Review'd 🎙️ Science News Daily | Peer Review'd Peer Review'd Practical Significance Practical Significance Amstat News Hugos There Podcast Hugos There Podcast Hugos There Podcast TED-Ed TED-Ed TED-Ed A Cut Above: Horror Review A Cut Above: Horror Review A Cut Above: Horror Review 天方烨谈 天方烨谈 基因频道 My Weird Prompts My Weird Prompts Daniel Rosehill Krigskunst Podcast Krigskunst Podcast Krigskunst Podcast Zero Knowledge Zero Knowledge Zero Knowledge Podcast
Decera Clinical Education Oncology Podcast

Science

Decera Clinical Education Oncology Podcast

Decera Clinical Education

Incorporating AKT1 and PIK3CA Pathway Testing and Targeted Therapies in the Management of Advanced Endocrine-Resistant Breast Cancer

June 30, 2026 1:57pm 24 min

Listen in to learn from Cristina Saura Manich, MD, PhD and Giampaolo Bianchini, MD about practical approaches to PI3K pathway testing, PI3K/AKT-targeted treatment options, and endocrine-based sequencing in metastatic bre...

Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider

June 22, 2026 10:16am 26 min

Link to claim CME credit: https://bit.ly/4uRr3ir In this episode, Elizabeth Krueger, NP, and Sam Vafadar, DHSc, PA-C, discuss how they optimize first-line EGFR-targeted therapy for patients with EGFR-mutated NSCLC, inclu...

Advancing the Early Detection of Lung Cancer: Expanding Screening Access, Eligibility, and Awareness

June 09, 2026 12:23pm 27 min

In this episode, Dr Abbie Begnaud discusses the importance of lung cancer screening and evolving strategies to improve early detection among high-risk populations, including: Low-dose CT screening, which reduces lung c...

HNSCC: Current and Emerging Therapeutic Strategies

May 29, 2026 4:01pm 26 min

In this episode,  Aarti Bhatia, MD, MPH, and  Deborah J. Wong, MD, PhD, discuss the rapidly evolving treatment landscape for recurrent, metastatic, and locally advanced head and neck squamous cell carcinoma (HNSCC), incl...

Navigating Relapsed/Refractory Multiple Myeloma: Real-world Use of Bispecific Antibodies

May 15, 2026 2:36pm 20 min

In this episode, hear Doris K. Hansen, MD, discuss the management of relapsed/refractory multiple myeloma with bispecific antibodies including: Practical differences among approved bispecific antibodies Toxicity profi...

Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma

May 07, 2026 8:14am 31 min

In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dos...

Thrombotic Events and ET/PV: What You Should Know

April 30, 2026 3:15pm 22 min

In this episode, hear Anthony Hunter, MD and Douglas Tremblay, MD discuss the various presentations of thrombotic events in patients with PV or ET including how thrombotic events may lead to diagnosis:  PV and ET incre...

Global Experts Discuss Current and Emerging Treatments for ET and PV

April 30, 2026 3:08pm 17 min

In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, i...

Global Experts Discuss Diagnostic Considerations in ET and PV

April 29, 2026 3:02pm 14 min

In this podcast episode, Ciro Rinaldi, MD, PhD, and Alessandro M. Vannucchi, MD, as they discuss contemporary topics in diagnosing essential thrombocythemia (ET) and polycythemia vera (PV), including: Overview of diagn...

Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer

April 17, 2026 1:05pm 22 min

In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer...

Patient Voices: Caring for the Whole Patient and Personalizing Treatment of Early Breast Cancer to Achieve Equitable Outcomes

April 15, 2026 3:55pm 41 min

A patient advocate/cancer survivor and a healthcare professional discuss key topics including early breast cancer diagnosis, role of self-agency in pursuing optimal cancer care, encouraging trial participation with patie...

Role of AKT and PI3K Inhibitors in Patients With HR-Positive Breast Cancers: Experts Share Their Thoughts on Current Practice and Future Opportunities

April 15, 2026 12:57pm 31 min

Podcast with global experts discussing the role of AKT and PI3K inhibitors in patients with resistance to endocrine therapy in the adjuvant or metastatic disease settings following current guidelines, indications, and be...

Patient-Centered Management of CDK4/6 Inhibitor Therapy: Adverse Event Mitigation, Adherence, and Persistence in HR+/HER2- Breast Cancer

April 14, 2026 2:56pm 44 min

In this episode, Danielle Roman, PharmD, BCOP, and Jordan Hill, PharmD, BCOP, discuss patient-centered management of CDK4/6 inhibitor therapy in HR-positive/HER2-negative breast cancer, with a focus on how oncology pharm...

TROP2-Directed Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer: Current Use in Clinical Practice and Future Directions

April 13, 2026 10:40am 33 min

In this episode, Dr Matthew Gubens and Dr Helena Yu discuss the evolving role of TROP2-directed therapies in non-small-cell lung cancer, with a focus on how antibody–drug conjugates (ADCs) fit into current treatment stra...

Emerging Therapies for Patients With HER2+ Gastroesophageal Adenocarcinoma and Biliary Tract Cancer

April 13, 2026 10:01am 39 min

In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the individualized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer...

Experts Discuss ADCs for HER2-Negative/Ultralow/Low MBC

March 26, 2026 8:13am 19 min

In this podcast episode, Aditya Bardia, MD, MPH, FASCO, and Ruta Rao, MD, discuss ADCs for HER2-negative/ultralow/low metastatic breast cancer, including: Classifying HER2 expression in MBC today (HER2 negative/ultralo...

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Colorectal Cancer

March 25, 2026 3:46pm 33 min

Advanced practice providers discuss biomarker testing in patients with colorectal cancer. Listen in to learn from Ann Marie Siney, RN, MSN, ANP-BC, and Kathleen Boyle, DScPAS, PA-C, about familial cancer syndromes associ...

Advanced Practice Professionals on Biomarker Testing in Patients With Solid Tumors: Prostate Cancer

March 25, 2026 9:06am 22 min

Listen to this audio podcast covering biomarker testing in patients with prostate cancer. Learn from Sara Traverso, MMS, PA-C, and Brenda Martone, MSN, ANP-BC, AOCNP, about when to conduct germline and somatic genetic te...

Bladder Cancer Breakthroughs: New NMIBC Therapies and EV + Pembrolizumab Updates From ASCO GU 2026

March 23, 2026 2:19pm 18 min

In this episode, Sam S. Chang, MD, MBA, and Matthew D. Galsky, MD, discuss the rapidly evolving treatment landscape in bladder cancer, highlighting new therapeutic options, emerging clinical trial data, including the lat...

Myth vs Medicine: Pharmacist’s Perspective on Adjuvant CDK4/6 Inhibitor Optimization

March 20, 2026 12:38pm 25 min

In this episode, oncology pharmacists Julia L. Ziegengeist, PharmD, BCOP, and Rodney Hunter, PharmD, BCOP, explore and challenge common assumptions about adjuvant CDK4/6 inhibitor use in high-risk HR+/HER2- early breast ...

Submit Your Favorite Station

Fill in the form below. Make sure to select both Country and Genres.

Name
Category
Hold Ctrl (Cmd on Mac) to select multiple.
Streaming URL
Logo (JPG, JPEG or PNG)

Contact us

Send us a message below. We will get back to you within 24 hours.

Subject
Your name
Email address
Station or page URL
Message
What is 15 plus 19?
We also attach your country, browser, current page, and device details to help us investigate issues.